G2AB.F 30.6 (+0%)
US92674R1023Drug ManufacturersDrug Manufacturers - Specialty & Generic

Vifor Pharma (G2AB.F) Stock Highlights

30.6 | +0%
2023-01-26 05:10:08
Vifor Pharma AG is a specialty drug manufacturing and licensing company. It researches, develops, and produces its pharmaceutical products and markets and distributes them worldwide. Most of its sales are generated in the USA, with Europe also a strong contributor. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Statistics

Range Today
30.6 30.6
Volume Today 0
Range 1 Year
28 38.8
Volume 1 Year 911
Range 3 Year
15.38 38.8
Volume 3 Year 2.34K
Range 10 Year
15.38 38.8
Volume 10 Year 2.34K

Highlights

Market Capitalization 11.62B (large)
Floating Shares 324.46M
Current Price 30.6
Price To Earnings 66.52
Price To Revenue 5.52
Price To Book 2.84
Earnings Per Share 0.46

Performance

Latest 0%
1 Month -3.16%
3 Months -10%
6 Months -7.27%
1 Year +0.66%
3 Years +39.09%
5 Years +39.09%
10 Years +39.09%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.